1. Home
  2. IOSP vs OCS Comparison

IOSP vs OCS Comparison

Compare IOSP & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innospec Inc.

IOSP

Innospec Inc.

HOLD

Current Price

$68.65

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

HOLD

Current Price

$25.43

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOSP
OCS
Founded
1938
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.6B
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
IOSP
OCS
Price
$68.65
$25.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$124.00
$41.86
AVG Volume (30 Days)
200.5K
381.4K
Earning Date
05-21-2026
01-01-0001
Dividend Yield
2.53%
N/A
EPS Growth
228.87
N/A
EPS
4.67
N/A
Revenue
$1,778,000,000.00
N/A
Revenue This Year
$5.96
$418.43
Revenue Next Year
$6.10
$892.34
P/E Ratio
$14.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$68.67
$14.00
52 Week High
$99.63
$30.68

Technical Indicators

Market Signals
Indicator
IOSP
OCS
Relative Strength Index (RSI) 21.23 38.55
Support Level N/A $19.00
Resistance Level $76.78 $29.23
Average True Range (ATR) 2.04 1.31
MACD -1.04 -0.43
Stochastic Oscillator 4.38 4.55

Price Performance

Historical Comparison
IOSP
OCS

About IOSP Innospec Inc.

Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Share on Social Networks: